iRhythm Holdings Inc. (IRTC)
IRTC trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/0001388658-26-000011-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | IRTC on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001388658 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DELAWARE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $747.1M |
| Net income | -$44.6M |
| Operating income | -$57.4M |
| Net margin | -6.0% |
| Operating margin | -7.7% |
| Revenue growth | +26.2% |
| Cash | $236.0M |
| Total assets | $1.0B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 4.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $394.7M cash; operating cash flow $13.9M a quarter. | Report 2026-09-30 |
| Shares outstanding | 33,618,146 (2026-10-29); 32,219,143 a year earlier; 30,650,758 three years earlier. | Cover page 2026-10-29 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, San Jose, California, United States; changed auditors 1 time in 24 months | 8-K 4.01 2026-04-01 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $57K, sold $27.9M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $221.6M | -$29.9M | $4.4M | $394.7M | No debt tags | $854.0M | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $224.2M | -$381K | $51.1M | $246.7M | No debt tags | $825.3M | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $199.4M | -$13.9M | -$26.2M | $240.1M | No debt tags | $787.9M | 10-Q 2026-04-30 |
| Q4 2025 2025-12-31 | $208.9M | $5.6M | $26.2M | $236.0M | No debt tags | $747.1M | 10-K 2026-02-19 |
| Q3 2025 2025-09-30 | $192.9M | -$5.2M | $34.9M | $255.6M | No debt tags | $702.6M | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $186.7M | -$14.2M | $27.7M | $309.1M | No debt tags | $657.2M | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $158.7M | -$30.7M | -$7.9M | $375.3M | No debt tags | $618.6M | 10-Q 2026-04-30 |
| Q4 2024 2024-12-31 | $164.3M | -$1.3M | $19.2M | $419.6M | $0 | $591.8M | 10-K 2026-02-19 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2020-08-19 |
| Latest annual report | 10-K | 2026-02-19 |
| Latest quarterly / interim | 10-Q | 2026-11-05 |
| Latest current report | 8-K | 2026-11-13 |
| Latest proxy | DEFA14A | 2026-04-17 |
Source: SEC EDGAR submissions feed, 855 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +1.9% |
| 1 month | -14.7% |
| 3 months | -25.4% |
| Year to date | -48.2% |
| 1 year | -45.5% |
| From 52-week high | -51.4% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| VVVV | vVARDIS Holding AG | $16.00 | -3.03% | $2.9B |
| ATRC | AtriCure Inc. | $55.31 | -2.69% | $2.8B |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | $46.36 | -8.09% | $3.4B |
| NVST | Envista Holdings Corporation | $24.03 | -1.88% | $3.9B |
| UFPT | UFP Technologies Inc. | $298.54 | -2.14% | $2.3B |
| HTFL | Heartflow Inc. | $46.86 | -3.30% | $4.1B |
| STVN | Stevanato Group S.p.A. | $15.53 | -1.71% | $4.2B |
| ICUI | ICU Medical Inc. | $181.87 | +1.45% | $4.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier